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ABSTRACT
CONTEXT AND OBJECTIVE: The prevalence and characteristics of gestational diabetes mellitus (GDM) 
have changed over time, reflecting the nutritional transition and changes in diagnostic criteria. We aimed 
to evaluate characteristics of women with GDM over a 20-year interval. 
DESIGN AND SETTING: Comparison of two pregnancy cohorts enrolled in different periods, in university 
hospitals in Porto Alegre, Brazil: 1991 to 1993 (n = 216); and 2009 to 2013 (n = 375).
METHODS: We applied two diagnostic criteria to the cohorts: International Association of Diabetes and 
Pregnancy Study Groups (IADPSG)/World Health Organization (WHO); and National Institute for Health 
and Care Excellence (NICE). We compared maternal-fetal characteristics and outcomes between the 
cohorts and within each cohort. 
RESULTS: The women in the 2010s cohort were older (31 ± 7 versus 30 ± 6 years), more frequently obe-
se (29.4% versus 15.2%), with more hypertensive disorders (14.1% versus 5.6%) and at increased risk of 
cesarean section (adjusted relative risk 1.8; 95% confidence interval: 1.4 - 2.3), compared with those in 
the 1990s  cohort. Neonatal outcomes such as birth weight category and hypoglycemia were similar. 
In the 1990s cohort, women only fulfilling IADPSG/WHO or only fulfilling NICE criteria had similar charac-
teristics and outcomes; in the 2010s cohort, women only diagnosed through IADPSG/WHO were more 
frequently obese than those diagnosed only through NICE (33 ± 8 kg/m2 versus 28 ± 6 kg/m2; P < 0.001). 
CONCLUSION: The epidemic of obesity seems to have modified the profile of women with GDM. Despite 
similar neonatal outcomes, there were differences in the intensity of treatment over time. The IADPSG/
WHO criteria seemed to identify a profile more associated with obesity.
RESUMO
CONTEXTO E OBJETIVO: Prevalência e características do diabetes mellitus gestacional (DMG) modifica-
ram-se com o tempo, refletindo transição nutricional e diferentes critérios diagnósticos. Nosso objetivo foi 
avaliar características de gestações com DMG em intervalo de 20 anos. 
TIPO DE ESTUDO E LOCAL: Comparação de duas coortes gestacionais arroladas em diferentes períodos, 
em hospitais universitários de Porto Alegre, Brasil: 1991 a 1993 (n = 216) e 2009 a 2013 (n = 375).
MÉTODOS: Aplicamos dois critérios diagnósticos às coortes: International Association of Diabetes and 
Pregnancy Study Groups (IADPSG)/Organização Mundial de Saúde (OMS); e National Institute for Health 
and Care Excellence (NICE). Comparamos características e desfechos materno-fetais entre as coortes e 
dentro de cada uma.
RESULTADOS: Na coorte dos anos 2010, as mulheres eram mais velhas (31 ± 7 versus 30 ± 6 anos), obesas 
(29,4% versus 15,2%), apresentaram mais distúrbios hipertensivos (14,1% versus 5,6%) e risco aumentado 
de cesariana (risco relativo ajustado 1,8; intervalo de confiança de 95% 1,4 - 2,3), comparadas às da coorte 
de 1990. Desfechos neonatais, como categoria do peso ao nascer e hipoglicemia, foram semelhantes. Na 
coorte de 1990, essas características e desfechos foram semelhantes nas mulheres que preenchiam ape-
nas um dos critérios; na de 2010, mulheres diagnosticadas apenas pelo IADPSG/OMS eram mais obesas 
(33 ± 8 kg/m2 versus 28 ± 6 kg/m2, P < 0,001) do que as diagnosticadas apenas pelo NICE.
CONCLUSÃO: A epidemia de obesidade parece ter modificado o perfil de mulheres com DMG. Embora 
desfechos neonatais sejam semelhantes, houve diferenças na intensidade de tratamento ao longo do 
tempo. O critério da IADPSG/OMS parece identificar um perfil mais associado à obesidade.
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INTRODUCTION
Gestational diabetes (GDM), initially defined as the highest gly-
cemic distribution values, has been surrounded by controversy, 
as detailed in the World Health Organization (WHO) position 
in 20131 and illustrated in a timeline.2 From the 1980s to 2010, 
two general procedures were in vogue, one based on a 2 h/75 g 
oral glucose tolerance test (OGTT) with two plasma glucose val-
ues and diagnostic criteria similar to those used outside of preg-
nancy, and another one based on a 3 h/100 g OGTT, with four 
pregnancy-specific plasma glucose cutoffs.1
Screening for gestational diabetes in Brazil was infrequent 
before the 1990s, but both OGTT procedures were increas-
ingly adopted thereafter. The 2 h/75 g OGTT gained wider 
acceptance after a 1997 consensus meeting3 at which GDM 
was defined using the intermediate hyperglycemic cutoffs 
that are used outside of pregnancy (fasting ≥ 110 mg/dl; 2 h 
≥ 140 mg/dl). This definition was validated using data from 
the Brazilian Gestational Diabetes Study (Estudo Brasileiro de 
Diabetes Gestacional, EBDG)4 and remained the main diag-
nostic criterion used in Brazil, usually with two-step screen-
ing based on fasting values.3 
In 2010, the International Association of Diabetes and 
Pregnancy Study Group (IADPSG) made new recommendations 
based on a 75 g OGTT and using data from the Hyperglycemia 
and Adverse Pregnancy Outcome (HAPO) study.1 Their recom-
mendations have been endorsed by various entities, but new 
controversies arose. Perhaps the most important of these was 
the observed increase in GDM prevalence, especially when 
applied universally.5,6 
This led other bodies to maintain the previous two-step diag-
nostic and screening procedures.1 In 2013, the World Health 
Organization (WHO) recommended the IADPSG criteria,1 although 
it warned of possible difficulties in implementing them. Alternatives 
to aid implementation were also proposed.7 In 2015, the British 
National Institute for Health and Care Excellence (NICE)8 made 
new recommendations. These are quite similar to the 1999 WHO1 
criteria for the 2 h value (140 mg/dl), but specifically define a lower 
fasting plasma glucose cutoff (100 mg/dl) that matches the cutoff 
for impaired fasting glucose established by the American Diabetes 
Association in 2004.9 This strategy had been previously suggested 
by the Latin American Diabetes Association, in 2007,10 and resem-
bles the one adopted in Brazil in 1997, although at that time, it 
was based on the impaired fasting glucose cutoff in vogue for use 
outside of pregnancy (110 mg/dl). Although the 1997 diagnostic 
criteria are still used in Brazil, the new IADPSG/WHO criteria are 
increasingly being adopted. The question that arises is whether the 
clinical profile of women detected through the IADPSG/WHO cri-
teria differs from the profile of those detected through the NICE 
criteria. Moreover, it can be asked whether these profiles have 
changed over time.
OBJECTIVE
The aim of the study was to evaluate changes in clinical character-
istics and maternal and offspring outcomes over 20 years, between 
two Brazilian cohorts of women with GDM, and compare them 
when classified through the IADPSG/WHO or NICE criteria.
METHODS
This study is a comparison of two cohorts of pregnant women 
in Brazil.
We studied two cohorts of women with GDM who had sin-
gleton pregnancies and at least one prenatal appointment in two 
university hospitals. A 75 g OGTT with two or three glucose mea-
surements was available for 560 (94.8%) women, while confirma-
tory fasting plasma glucose data was available for 31 (5.2%). We 
applied two recent criteria for GDM to both cohorts:
1. the IADPSG/WHO criteria: FPG ≥ 92 mg/dl or 1-h plasma 
glucose ≥ 180 mg/dl or 2-h plasma glucose ≥ 153 mg/dl;1 and
2. the NICE criteria: fasting plasma glucose (FPG) ≥ 100 mg/dl 
or 2 h plasma glucose ≥ 140 mg/dl.8
The first cohort was composed of 216 women who met either of 
the two contemporary criteria for GDM (IADPSG/WHO or NICE). 
This cohort was derived from a cohort of 1031 women who were 
enrolled between 1991 and 1993, in general prenatal clinics of two 
university hospitals in Porto Alegre, which was one of the centers 
of the EBDG study.4 In the original cohort, cases with known pre-
gestational diabetes had been excluded at the time of booking, and 
only the cases that reached diabetes levels outside of pregnancy had 
been treated.11
The second cohort was recruited between November 2009 
and December 2013 and was composed of 375 women who had 
been referred to a high-risk pregnancy prenatal clinic at a public 
university hospital located in the southernmost state of the coun-
try, which provides medical care through the Brazilian National 
Health System (Sistema Único de Saúde, SUS). In 2013, around 
3,800 babies were delivered at the hospital and the cesarean rate was 
35.16%.12 All eligible women with singleton pregnancies who had 
a diagnosis of GDM through either of the two GDM criteria were 
included and cared for by a multidisciplinary team. The dietary 
counseling differed according to the individuals’ BMI and gesta-
tional stage, and emphasized low glycemic index and carbohy-
drates, along with high intake of fiber-rich foods.
We collected information on sociodemographic characteris-
tics, medical history and pregnancy outcomes. The pre-gestational 
weight was obtained through self-reporting. Weights and heights 
were measured with the subjects wearing light clothes and no 
shoes. Use of diets, insulin and oral medications (metformin or 
glyburide) were considered to be “any treatment”. Data on preg-
nancy follow-up, delivery and maternal and newborn outcomes 
were retrieved from medical files.
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A positive family history of diabetes was defined as among first-
degree relatives, and gravidity, as the number of pregnancies including 
the current one. Pre-gestational BMI was calculated as the informed 
pre-pregnancy weight divided by the square of the height and catego-
rized according to the current WHO classification.13 Total weight gain 
was calculated as the difference between the last registered weight 
(measured at delivery or at the last prenatal appointment) and the 
informed pre-pregnancy weight. The 2009 Institute of Medicine 
recommendations were used to classify weight gain adequacy: for 
underweight women, 12.5 to 18 kg; normal BMI, 11.5 to 16 kg; over-
weight, 7 to 11 kg; and obese, 5 to 9 kg.14 Hypertensive-related dis-
orders of pregnancy were a composite of gestational hypertension, 
preeclampsia and eclampsia, as defined by the International Society 
for the Study of Hypertension in Pregnancy (ISSHP).15
We used the Alexander birth weight chart16 to classify new-
borns as small for gestational age (SGA) or as large for gestational 
diabetes (LGA), according to birth weight and gestational age. The 
latter was based on the first day of a reliable last menstrual period 
or on first-trimester ultrasonography. Macrosomia was defined 
as birth weight ≥ 4,000 g at term, and preterm birth, as delivery at 
less than 37 gestational weeks.17
The ethics committees of both hospitals approved the study pro-
tocols (number 90-058 for the 1990s cohort and number 10-0364 
for the 2010s cohort). Informed consent was obtained from all 
individual participants included in the study.
Statistical analysis
The data are presented as means (with standard deviation) or pro-
portions (%). Student’s t test and Pearson’s χ2 test (with the Z test 
for comparison of proportions and Bonferroni’s correction) were 
used to compare the two GDM groups. Kappa statistics were used 
to calculate the level of agreement between the two diagnostic cri-
teria. For adjustment of outcomes, we performed Poisson regres-
sion with robust variance and, in the models, we included the 
mothers’ baseline characteristics that were significant in univari-
able analyses. The outcomes assessed were: hypertensive disor-
ders, cesarean section, preterm delivery, birth weight, frequencies 
of SGA and LGA, macrosomia, malformation, hypoglycemia and 
perinatal death. The 1990s cohort was taken to be the as reference 
and the results were presented as crude and adjusted relative risk 
(RR) and 95% confidence interval (CI). The statistical analyses 
were performed using the SPSS software, version 18.8. Statistical 
significance was set at 0.05, and was taken to be two-sided. 
RESULTS
The main characteristics of the two cohorts are shown in Table 1. 
Age, schooling and gravidity were greater in the recent cohort, 
while living with a partner and smoking decreased, the lat-
ter in a remarkable way (33.3 to 9.6%). The nutritional charac-
teristics also changed importantly, such that the women of the 
2010s cohort were notably more obese (45.1 versus 15.2%) before 
becoming pregnant and reached a higher weight at delivery 
(86 ± 18 versus 74 ± 12 kg). Accordingly, the plasma glucose val-
ues for the 2010s cohort were higher, based on fasting, 1 h and 2 
h values. Additionally, the diagnosis of GDM was reached slightly 
earlier for the 2010s cohort and treatment was notably more fre-
quent. The women of the 2010s cohort reported having markedly 
greater family histories of diabetes and having had a previous 
pregnancy with GDM. Although not statistically significant, a 
trend towards higher frequency of chronic hypertension was also 
observed, with slightly higher levels of diastolic blood pressure.
As seen in Table 2, the women of the 2010s cohort ended their 
pregnancies with a slightly shorter duration and higher frequency of 
cesarean section. Pregnancy-related hypertension was more frequent 
but total gestational weight gain and adequacy of gestational weight 
gain did not differ much between the two cohorts. The main offspring 
Table 1. Characteristics of women in two gestational diabetes 
cohorts*, 20 years apart
Characteristic
1990s cohort
n = 216
2010s cohort
n = 375
P-value†
Mean (SD)
or %
Mean (SD)
or %
Age (years) 30 (6) 31 (7) 0.004
White skin color 
(versus non-white)
71.3 74.1 0.514
Schooling (≥ 11 years) 4.2 48.3 < 0.001
Living with partner 94 61.1 < 0.001
Gravidity 2.2 (2.2) 2.7 (1.6) 0.005
Current smoking 33.3 9.6 < 0.001
Family history 16.8 51.2 < 0.001
Previous GDM 1.4 13.9 < 0.001
Pre-gestational weight (kg) 63 (11) 76 (18) < 0.001
Pre-gestational BMI (kg/m2) 26 (4) 30 (7) < 0.001
BMI categories (kg/m2)
< 25‡ 49.3 25.5
< 0.001 25 ≤ BMI < 30 35.5 29.4
≥ 30 15.2 45.1
Chronic hypertension 8.3 13.6 0.074
Systolic BP (mm/Hg) 118 ± 14 117 ± 12 0.191
Diastolic BP (mmHg) 72 (10) 73 (10) 0.154
Gestational age, diagnosis 
(weeks)
25 (3) 24 (6) < 0.001
Diagnostic OGTT (mg/dl)
Fasting 95 (9) 99 (23) 0.012
1 hour 153 (37) 180 (34) < 0.001
2 hour 126 (3) 162 (33) < 0.001
Any GDM treatment§ 5.1 52.5 < 0.001
BMI = body mass index; BP = blood pressure; GDM = gestational diabetes 
mellitus; OGTT = oral glucose tolerance test. *Gestational diabetes 
diagnosed through the criteria of either IADPSG/WHO (International 
Association of Diabetes and Pregnancy Study Groups/World Health 
Organization) or NICE (National Institute for Health and Care Excellence); 
†Means (with standard deviation, SD) were compared using Student’s t 
test; proportions (%) were compared using Pearson’s χ2 test, with the Z 
test for proportions, adjusted using Bonferroni’s correction. ‡Includes one 
woman with BMI < 25 kg/m2 in each cohort; §Any GDM treatment: diet for 
the 1990s cohort and diet + oral drug or insulin for the 2010s cohort.
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outcomes were similar. Although not statistically significant, perinatal 
mortality decreased from 33/1,000 to 18/1,000. The adjusted relative 
risks of the main outcomes showed that there was higher risk of cesar-
ean section in the 2010s cohort (Table 2). Although the difference in 
gestational age at delivery was significant in univariable analyses (5 
days less in the 2010s cohort), the rates of preterm delivery were simi-
lar between the cohorts (14.9 versus 16.3%; P = 0.744).
In the 1990s cohort, the NICE criteria would label 51.4% 
of women as having GDM, while the IADPSG/WHO criteria 
would label 94.5% as having GDM. In the 2010s cohort, 87.0% would 
meet the NICE criteria and 90.9%, the IADPSG/WHO criteria. 
The overall agreement between the two diagnostic criteria, exam-
ining the two cohorts together, was 68% (95% CI: 66-70%) but, 
as shown in Figure 1, the rate of agreement was greater for the 
2010s cohort (43.5% in the 1990s cohort and 77.8% in the 2010s 
cohort). The proportion of the remaining cases that would be 
detected through only one of the two criteria decreased over time 
for those only meeting the IADPSG/WHO criteria (48.0% versus 
13.1%) but not for those only meeting the NICE criteria. 
We then compared the clinical characteristics and outcomes 
for women only meeting the NICE criteria or only meeting the 
IADPSG/WHO criteria for the two cohorts (Table 3). Although 
the numbers became small, it was apparent that women only meet-
ing the IADPSG/WHO criteria had higher BMI and pre-gestational 
weight and showed a trend towards excessive gestational weight 
Table 2. Maternal and offspring outcomes in two gestational diabetes cohorts*, 20 years apart
Outcome
1990s cohort
n = 216
2010s cohort
n = 375
P-value†
RR‡
(95% CI)
aRR‡
(95% CI)Mean (SD) 
or %
Mean (SD) 
or %
Mother
Weight at delivery (kg) 74 (12) 86 (18) < 0.001
Weight gain at delivery (kg) 11 (7) 10 (8) 0.120
Gestational age, delivery (weeks) 38.3 (2.9) 37.8 (1.4) 0.005 § §
Weight gain 
Insufficient 34.3 37.7
0.366Adequate 30.5 25.1
Excessive 35.2 37.2
Pregnancy hypertension|| 5.6 14.1 0.002 2.5 (1.4-4.7) 1.8 (0.9-3.6)
Cesarean section|| 30.4 56.5 < 0.001 1.9 (1.5-2.3) 1.8 (1.4-2.3)
Offspring
Birth weight (g) 3228 (615) 3242 (575) 0.774
Birth weight classification
SGA 10.3 8.8
0.589AGA 79.9 78.9
LGA 9.8 12.3
Macrosomia 8.4 8.3 0.951
Malformation 3.7 2.4 0.502
Hypoglycemia 6.5 9.7 0.239
Perinatal death 3.3 1.8 0.432
95% CI = 95% confidence interval; AGA = adequate for gestational age; aRR = adjusted relative risk; LGA = large for gestational age; RR = relative risk; SGA = small for 
gestational age. *Gestational diabetes diagnosed through the criteria of either IADPSG/WHO (International Association of Diabetes and Pregnancy Study Groups/World 
Health Organization) or NICE (National Institute for Health and Care Excellence). †Means (with standard deviation, SD) were compared using Student’s t test; proportions (%) 
were compared using Pearson’s χ2 test, with the Z test for proportions, adjusted using Bonferroni’s correction. ‡Poisson regression with robust variance; §See comment in 
Results section; ||Adjusted for center, age, schooling, gravidity, smoking, previous gestational diabetes mellitus (GDM) and pre-gestational body mass index (BMI).
Only NICE Only IADPSG/WHOBoth
17
(7.9%)
105
(48.6%)
94
(43.5%)
Only NICE Only IADPSG/WHOBoth
34
(9.1%)
49
(13.1%)
292
(77.8%)
1990s
2010s
Figure 1. Overlap of NICE criteria and IADPSG/WHO criteria in 
two gestational diabetes cohorts 20 years apart
NICE = National Institute for Health and Care Excellence; IADPSG/
WHO = International Association of Diabetes and Pregnancy Study 
Groups/World Health Organization.
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gain and delivery of heavier babies, but showed less neonatal hypo-
glycemia. Conversely, women only meeting the NICE criteria had 
higher rates of neonatal hypoglycemia. For both cohorts, the mean 
fasting plasma glucose was higher and the 2 h plasma glucose was 
lower for women who only met the IADPSG/WHO criteria.
DISCUSSION
The women in the more recent cohort of GDM were more obese, 
had higher plasma glucose values at diagnosis, higher fre-
quency of pregnancy-related hypertension and higher adjusted 
risk of cesarean section than the previous cohort, which had 
been assembled about 20 years earlier. They were also more 
frequently treated for GDM. Newborn outcomes were similar 
over time, except for a downward trend in perinatal mortality. 
We found a very good overlap (Figure 1) between those diag-
nosed through the IADPSG/WHO and through the NICE cri-
teria in the 2010s cohort. Women only meeting the IADPSG/
WHO cutoffs showed a profile more associated with the effects 
of the ongoing obesity epidemic.
The differences observed between the two cohorts may reflect 
the nationwide public policies that have been adopted, which have 
resulted in better social indicators, as revealed by an increasing 
Human Development Index (from 0.608 in 1990 to 0.755 in 2014).18 
This attainment is reflected in the higher schooling levels, later preg-
nancies (surprisingly, in contrast to higher gravidity) and better health 
indicators (such as lower rates of smoking)19 that have been seen in 
the whole Brazilian population.18 Furthermore, implementation of a 
national health system,19 which has enabled almost universal access to 
diagnosis and treatment for gestational diabetes, may have contrib-
uted, at least partly, to the differences found between the two cohorts.
However, the effects of the obesity epidemic have hampered 
these successes. Brazil moved up from 9th position, in 1975, to 5th 
position, in 2014, in the ranking of female obesity.20 Maternal obe-
sity increased remarkably, revealed here through an average pre-
gestational weight increase of 10 kg, in just 20 years between the 
two GDM cohorts. On average, the women in the 1990s cohort 
began pregnancy within the overweight category, whereas those 
in the 2010s cohort did so within the obesity category. Given that 
maternal obesity confers important adverse outcomes for both 
the mother and the child, and possibly for future generations,21 
this epidemic rise in obesity threatens the progress in pregnancy 
outcomes that has already achieved. It also puts at risk the attain-
ability of the goals for reducing the burden of non-communicable 
diseases by 2025, a challenge faced by Brazil and all other nations. 
Hyperglycemia and obesity share common metabolic pathways 
and characteristics, and thus lead to consequences that are probably 
indissoluble, with additive effects on GDM outcomes.22 It is appar-
ent that the effects of the obesity epidemic were fully manifested in 
our current cohort: the women were remarkably more obese, pre-
sented pregnancy hypertension more often and were at higher risk 
of cesarean section. Birth weight and the large-for-gestational-age 
rate among the newborns did not differ between the two cohorts, 
perhaps because of the more widespread treatment for GDM in 
the recent cohort.
Table 3. Characteristics and pregnancy outcomes of two gestational diabetes cohorts defined only through the NICE criteria or only 
through the IADPSG/WHO criteria
Characteristic
1990s cohort 2010s cohort
Only NICE 
n = 17 (7.9)
Only IADPSG/WHO 
n = 105 (48.6) P-value
Only NICE 
n = 34 (9.1)
Only IADPSG/WHO 
n = 49 (13.1) P-value*
Mean (SD) or % Mean (SD) or % Mean (SD) or % Mean (SD) or %
Pre-gestational BMI (kg/m2) 23.2 (3.2) 25.5 (4.8) 0.059 28 (6) 33 (8) < 0.001
Pre-gestational weight (kg) 57 (9) 63 (13) 0.064 68 (16) 87 (21) < 0.001
OGTT (mg/dl)
Fasting 83 (7)† 94 (4)‡ < 0.001 84 (6)† 94 (5)‡ < 0.001
2 hours 146 (4)§ 107 (19)|| < 0.001 146 (3)§ 116 (18)|| < 0.001
Any treatment 0 0 35.3 36.7 0.893
Insulin use 0 0 2.9 10.2 0.393
GWG category
Insufficient 23.5 36.9
0.422
38.2 35.4
0.467Adequate 41.2 27.2 32.4 22.9
Excessive 35.3 35.9 29.4 41.7
Gestational hypertension 5.9 3.8 0.534 8.8 14.3 0.515
Cesarean section 41.2 24.8 0.237 55.9 42.9 0.271
Birth weight 3412 (637) 3194 (561) 0.147 3059 (498) 3313 (504) 0.026
Newborn hypoglycemia 0 2.9 > 0.999 14.7 2.0 0.040
BMI = body mass index; GWG = gestational weight gain; IADPSG/WHO = International Association of Diabetes and Pregnancy Study Groups/World Health 
Organization; NICE = National Institute for Health and Care Excellence; OGTT = oral glucose tolerance test. Student’s t test for glycemic cutoffs: *Means (with 
standard deviation, SD) were compared using Student’s t test; proportions (%) were compared using Pearson’s χ2 test, with the Z test for proportions, adjusted  
using Bonferroni’s correction; †P = 0.598; ‡P > 0.999; §P > 0.999; |||P = 0.006. 
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Within this scenario, over the last few years, we have faced 
the challenge of adopting new diagnostic criteria, following the 
new recommendations from IADPSG in 2010 and WHO in 2013. 
Our main concern is that these criteria are likely to increase the 
prevalence of gestational diabetes,23 both as a result of the epi-
demic of maternal obesity and as a consequence of only requir-
ing one altered cutoff for a diagnosis of GDM. Previous estimates 
indicated that changing from the 1997 Brazilian criteria to the new 
IADPSG/WHO criteria would raise the frequency of GDM from 
7.6% to 18.0%, i.e. a 2.5-fold increase.24
As illustrated in Figure 1, by applying each criterion to the 
diagnostic test for women with GDM, the IADPSG/WHO criteria 
labeled a higher number of women in both cohorts as presenting 
GDM, although the rate of disagreement between the two crite-
ria was lower in the 2010s cohort (down from 56.5% to 22.2%). 
The rate of agreement between the two different criteria varies 
across studies, from 49.7%25 or 50.6%26 to 65.6%.27 This partial 
overlap suggests that these studies probably reflect distinct GDM 
profiles. In one study that compared the NICE and the IADPSG/
WHO criteria, 55.1% of the women with GDM would be detected 
by both criteria, which was lower than the overlap that we found 
in the 2010s cohort.28 It is possible that differences we found for 
the 2010s cohort concerning maternal weight and birth weight 
reflected the effects of the current obesity epidemic and associated 
factors, particularly in relation to those only meeting the IADPSG/
WHO criteria. In a recent study comparing obese women with and 
without GDM in the first trimester of pregnancy, obesity markers 
such as insulin resistance and higher BMI were more frequent in 
those with GDM, along with higher glucose levels. It was suggested 
that application of IADPSG/WHO to the DALI cohort had “iden-
tified a profile akin to the metabolic syndrome”.29 Moreover, to be 
worthwhile, adoption of a GDM criterion that enhances preva-
lence should also increase the detection rate of relevant clinical 
outcomes. Given the low attributable fractions relating to hypergly-
cemia (6.7% for large for gestational age and 3.5% for preeclamp-
sia, based on the IADPSG/WHO criteria),24 increased detection 
of relevant outcomes is likely to be small. 
The main strength of our study is that it enables comparison 
between the features of a recent GDM cohort with those of an old 
one. We were able to document the important effect of the obe-
sity epidemic over this 20-year interval. The major limitation of 
our study relates to the source of the cohorts: the 1990s cohort 
was derived from a large sample and had little intervention for 
treatment, and although the study was directed from university 
hospitals, the women were attending general prenatal care. On the 
other hand, for the 2010s cohort, enrollment was at a specialized 
clinic of a university hospital and women with greater severity of 
hyperglycemia may have been included. These women more fre-
quently presented histories of family diabetes and previous GDM. 
This could have biased our results; nevertheless, diabetes rates are 
also increasing worldwide30 and this trend could potentially explain 
these findings. Intensive treatment in the 2010s cohort limited inter-
pretation of pregnancy outcomes. Finally, only a few of our cases 
met only one criterion or the other, which limited the extrapola-
tion of our data. Even so, some subtle differences were revealed.
CONCLUSION
Important effects reflecting the nutritional transition over time 
were documented through evaluation of these two GDM cohorts 
separated by a 20-year interval, and some differences in applying 
two different GDM criteria were apparent. Women only meet-
ing the IADPSG/WHO criteria presented pregnancy features 
that were often linked to obesity, while those meeting the NICE 
criteria presented worse neonatal outcomes, here represented by 
hypoglycemia. Further studies focusing on the combined effects 
of the obesity epidemic and hyperglycemia will help to clarify 
similarities and differences, and whether these are real, in the 
profile of pregnancies diagnosed through these two currently 
used GDM criteria.
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